SCHEMBL24257838

SCHEMBL24257838

CCOc1ccc(S(=O)(=O)Nc2ncc(C(=O)O)cn2)cc1

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 3/20 0.68
▸ MAPT P10636 2/20 0.57
▸ KMT2A Q03164 2/20 0.57
▸ MEN1 O00255 1/20 0.57
▸ ALDH1A1 P00352 5/20 0.55
▸ KDM4E B2RXH2 2/20 0.55
▸ RCE1 Q9Y256 1/20 0.55
▸ LMNA P02545 4/20 0.54
▸ MAPK1 P28482 1/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ SQSTM1 Q13501 1/20 0.52
▸ KEAP1 Q14145 1/20 0.52
▸ NFE2L2 Q16236 1/20 0.52
▸ PKM P14618 1/20 0.52
▸ HTT P42858 2/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ GAA P10253 1/20 0.51
▸ RAB9A P51151 1/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22079982 0.84 TDP1 (0.52) TDP1MAPTKMT2AMEN1ALDH1A1
SCHEMBL22080432 0.82 TDP1 (0.61) TDP1KMT2AMEN1ALDH1A1LMNA
SCHEMBL24257837 0.81 TP53 (0.48) TDP1MAPTKDM4ELMNASMN1; SMN2
SCHEMBL22079909 0.80 AKT1 (0.48) TDP1KDM4E
SCHEMBL22080431 0.78 KDM4E (0.54) MAPTKMT2AMEN1ALDH1A1KDM4E
SCHEMBL26786077 0.78 HDAC1 (0.46) TDP1MAPTLMNASMN1; SMN2HTT
SCHEMBL5317757 0.77 TDP1 (0.65) TDP1MAPTKMT2AMEN1ALDH1A1
SCHEMBL8752453 0.74 KMT2A (0.91) TDP1MAPTKMT2AMEN1ALDH1A1
SCHEMBL24257833 0.74 ALDH1A1 (0.56) TDP1MAPTKMT2AMEN1ALDH1A1
SCHEMBL8240251 0.73 TDP1 (0.60) TDP1KMT2AMEN1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220048968-A1 INSULIN CONJUGATES SANOFI (FR) 2022-02-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048968-A1 INSULIN CONJUGATES IAPP, INSR, IGF1R TDP1 4783/4885MAPT 3611/4885KMT2A 953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback